Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02995538 · ClinicalTrials.gov registry record
Neurogenetics Patient Registry
A clinical trial of Neurogenetic Disorders, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT02995538: Recruiting study of Neurogenetic Disorders, sponsored by University of Pittsburgh.
NCT02995538 is a study of Neurogenetic Disorders that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 1,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02995538, a study of Neurogenetic Disorders, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this project is to develop a Neurogenetics patient database and bio repository - which includes clinical information regarding history, physical examination, laboratory testing including genetic testing (NextGen sequencing including whole exome and whole genome sequencing, SNParray, etc.), neuroradiology studies, neurophysiology studies - all ordered as clinically deemed appropriate, natural history from clinical longitudinal follow-up and to use de-identified information from this registry/ repository, when appropriate for clinical and translational research.
Primary Outcome
Next generation sequencing, if clinically appropriate will be ordered through available commercial labs as approved by the patient's insurance company. If insurance coverage is denied research testing will be ordered after informed consent and pretesting counseling, to be done through our collaborative labs.
Conditions Studied
Study Locations (1)
Pennsylvania
- Children's Hospital of Pittsburgh of UPMC - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2017-01-30 |
| Est. Completion | 2028-01 |
What NCT02995538 shows while recruiting
NCT02995538 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Neurogenetic Disorders appearing as the primary indexed condition, and to 0 interventions.
NCT02995538 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02995538 about?
NCT02995538 is a clinical study titled "Neurogenetics Patient Registry". The objective of this project is to develop a Neurogenetics patient database and bio repository - which includes clinical information regarding history, physical examination, laboratory testing including genetic testing (NextGen sequencing including whole exome and whole genome sequencing, SNParray,...
What is the current status of trial NCT02995538?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2017-01-30. Estimated completion is 2028-01.
What conditions does trial NCT02995538 study?
This clinical trial studies the following conditions: Neurogenetic Disorders.
Who is sponsoring clinical trial NCT02995538?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02995538 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI